Tauriga Launches CBD Infused Tauri-Gum™

CBD INFUSED TAURI-GUM™ IS TAURIGA’S FIRST GUM PRODUCT

Company News


Welcome To Tauriga Sciences

Tauriga Sciences would like to thank all its loyal shareholders as well as welcome new shareholders. Management believes 2019 has the potential to be an exciting year for the Company.  Over the course of the past year, Management has been working diligently to both restore and create shareholder value for the Company’s shareholders.

The Company has previously indicated in press releases and SEC Filings, its intent to pursue a major potential acquisition(s) and or product development initiative(s).  The Company is actively evaluating potential merger and acquisition candidates and is taking steps to amend its capital structure so that its structure is amenable to such a transaction (should the Company decide to move forward with a potential opportunity).  Over the past year, the Company has also been contemplating opportunities involving product development and commercialization initiative(s).

One such opportunity on which the Company has acted (initially disclosed during December 2018), involves the Company entering into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases. This CBD infused chewing gum product has been branded under the following name: Tauri-Gum™. See also our periodic reports filed by us with the SEC for a more complete description of our business and material agreements that we have entered into.  Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at www.tauriga.com.

In addition, the Company is currently constructing an E-Commerce site for the sale of its CBD Infused Chewing Gum.  This site is being constructed under the following URL address:  www.taurigum.com

Tauri-Gum™ CBD INFUSED CHEWING GUM
Tauriga Sciences Inc. (“Tauriga”), through a contract manufacturing agreement with Maryland based Per Os BioSciences LLC, has developed a CBD Infused Chewing Gum Product Line (“CBD Gum”), branded under the name: Tauri-GumTM.  This CBD Gum has been manufactured via a patented process (as expressed by U.S. Patent # 9,744,128 – wholly owned by the manufacturer) and is distributed exclusively by Tauriga.  The CBD Gum is Gluten-Free, Non-GMO, Allergen-Free, Vegan, Kosher (formally certified as Kosher on January 29, 2019 by Star-K), and Pareve (non-dairy).  The initial production run is being completed exclusively in Mint flavor and the product is only being sold to individuals of age 18 and older.  This is a high quality product, 3rd party tested (for Quality Assurance), and drug test safe. The Company officially launched  Tauri-Gum TM on March 11th, 2019 and has a dedicated E-Commerce site under the URL Address: www.taurigum.com.
The Company has announced that both individual packs and retail display boxes of will be for sale.  The individual pack contains 8 large gum chewing gum tablets (each containing 10mg of CBD Isolate).  The retail display box (“retail box”) contains 10 individual packs.
The Company has been assigned distinct GS1 Barcodes for both the individual pack as well as the retail box.  The Company expects to sell each individual pack for $17.99 and each retail box for $179.99.  There will be no shipping fees assessed for orders of 2 or more individual packs or one or more retail boxes.



 

Star-K Kosher Certification
kosher-logo

Formally certified as Kosher on January 29, 2019 by Star-K

Click Here to download PDF

Investments

 

VistaGen Therapeutics – The Company has an equity position in VistaGen Therapeutics. VistaGen is a biotech that currently conducting trials in the areas of non-opioid pain, anxiety and depression. More information regarding  Vistagen’s portfolio and trials on its corporate website; www.vistagen.com.

Recent Press Releases

Fully committed to commercializing innovation to enhance personal wellness, improve our environment and create lasting shareholder value.